SMAD2 and neoplasm: This is very concerning, as it was reported that GRP78 and CRIPTO overexpression in the cancer cells activate MAPK/AKT signaling, Src/PI3K/AKT, and Smad2/3 pathways leading to tumor proliferation, plasticity, and resistance to apoptosis.